The MISSION of The Brain Tumor Immunology Foundation (BTIF) is to help save the lives of those with Primary Brain Cancer with the hope that new research will eventually lead to successfully treating Metastatic Brain Tumors and children diagnosed with Pediatric Brain Tumors.
We believe that the promising work of Dr. Carol Kruse may help to make the difference between a healthy life, and one cut short by Brain Cancer. Dr. Kruse's research is currently undergoing Clinical Trials at the Ronald Reagan UCLA Medical Center.
An anonymous donor established the Brain Tumor Immunology Foundation so that brain tumor patients who could benefit from cellular immune therapy would not die while government funding for the clinical trial was pending.
In 1995, Dr. Kruse and her team initiated a six-patient pilot study using a less-developed version of this therapy. These patients failed all conventional options and chose enrolling in this study over entering hospice. The outcome: Three of six patients were long-term survivors! One patient lived 40-months post treatment. Two other patients are alive today with no evidence of adverse effects or need for subsequent therapy.
Below is the intimate story of one of the original patients who,
is still alive, and healthy today, more than 16 years later.
An anonymous donor established the Brain Tumor Immunology Foundation so that brain tumor patients who could benefit from cellular immune therapy would not die while government funding for the clinical trial was pending.
In 1995, Dr. Kruse and her team initiated a six-patient pilot study using a less-developed version of this therapy. These patients failed all conventional options and chose enrolling in this study over entering hospice. The outcome: Three of six patients were long-term survivors! One patient lived 40-months post treatment. Two other patients are alive today with no evidence of adverse effects or need for subsequent therapy.
Below is the intimate story of one of the original patients who,
is still alive, and healthy today, more than 16 years later.
Primary Brain Cancer is Among the Most Lethal of All Cancers
Imagine being a healthy young adult. Then, the debilitating headaches start. The nausea and confusion intensify. After a series of tests, you hear the unthinkable: "You have a tumor, cancer of the brain. It is incurable."
It happened to Tracy, then a young pediatric nurse who was told she would likely die within two years. That was more than 16 years ago. Today, Tracy has no evidence of a brain tumor - as evidence by annual MRI evaluation. She credits a ground-breaking immune therapy for saving her life. The researcher behind the treatment is Dr. Carol Kruse. After losing her husband to brain cancer in 1974 Dr. Kruse devoted her life to finding a cure. Today her work is under clinical trials at the Ronald Reagan UCLA Medical Center. |
FOUNDATION DONORS believe in the Promising
|
